Location: Home
  • search
  • go
  • Relate News
  • 5/24/2019NMPA Issues the Provisions for Import of Herbal Materials
  • 5/24/2019The State Council Appoints New Minister of SAMR
  • 5/23/2019NHC Issues Notice to Initiate Trial for Urban Medical Consortium Build...
  • 5/23/2019Review of Chinese Foreign Trade of Western Medicines in 2018
  • 5/23/2019Amgen's Denosumab Conditionally Approved in China
  • 5/23/2019Joinn Labs to Buy Clinical CRO Biomere for $27.3M
  • 5/22/2019China: Survival of the Fittest or Cheapest?
  • 5/21/2019WuXi STA and Dizal Pharma Sign CMC Development and Manufacturing Agree...
  • 5/21/2019WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufactu...
  • 5/21/2019Mabpharm Announces Proposed Listing on Hong Kong Stock Exchange
  • 5/21/2019European Chamber Report Calls for Urgent China Reforms amid Increasing...
  • 5/20/2019Premier Li Urges More Efforts to Advance Healthcare Reforms
  • 5/20/2019China Raises Tariffs on U.S. MedPharm Products to 25% as Part of Its R...
  • 5/17/2019Recent Executive Moves
  • 5/17/2019China Approves Pfizer's Anticancer VIZIMPRO (dacomitinib)
  • 5/17/2019China Proposes Major Changes to Pharmaceutical Regulations
  • 5/16/2019Performance Overview of A Share-Listed Chinese MedPharm Cos 2018-Q1/20...
  • 5/16/2019Performance of Top 15 Listed Chinese Drug Companies 2018
  • 5/16/2019A Birds-Eye-View of the Diabetes Drug Market of Major Provincial Level...
  • 5/16/2019One Min to Understand the Changes in the New Chinese Anti-Competition ...
  • 5/16/2019WuXi Bio Builds Integrated Manufacturing Center for Innovative Biologi...
  • 5/16/2019Cumberland and Winhealth Enter Licensing Deal for Two Injection Drugs
  • 5/15/2019NHC Requires Enhanced Reporting of Hospital Statistical Data
  • 5/14/2019China Issues New Policy Document to Launch Trial for Development of Pr...
  • 5/14/2019Big Pharma Companies Deliver Stunning Chinese Growth in Q1/2019 and 20...
  • 5/14/2019New Report: As Star mAb Drug Patents Expire, Generic Drugs will Shock ...
  • 5/13/2019China to Raise Reimbursement Ratio of Critical Illness Program to 60% ...
  • 5/13/2019NMPA Deepens Regulatory Harmonization with Hong Kong and Macau
  • 5/10/2019Recent Executive Moves
  • 5/10/2019PhRMA Calls for Trade Deals That Force Countries to Pay More for Drugs
  • Page:161/378 Total number of articles:11313: [First][<<] [159] [160] [161] [162] [163] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group